Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Leap Therapeutics (NASDAQ:LPTX) reported its Q4 earnings results on Monday, March 18, 2024 at 07:00 AM.
Here's what investors need to know about the announcement.
Leap Therapeutics beat estimated earnings by 16.0%, reporting an EPS of $-0.46 versus an estimate of $-0.55.
Revenue was down $0 from the same period last year.
Last quarter the company beat on EPS by $0.07 which was followed by a 9.0% increase in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Leap Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: LPTX